GlobeNewswire

Kitron: Q4 2020 - Strong finish to an exceptional year

Share

(2021-02-11) Kitron today reported quarterly figures showing a solid end to a full year characterized by exceptional growth and margin expansion, leading the Board of Directors to propose a 40 percent increase in the annual dividend.

Kitron's revenue for the fourth quarter was NOK 992 million, an increase of 12 per cent compared to last year. Growth adjusted for currency effects was 7 per cent.

Profitability expressed as EBIT margin was 7.6 per cent in the fourth quarter, compared to 6.1 per cent in the same quarter last year.

The order backlog ended at NOK 2 006 million, an increase of 6 per cent compared to last year.

Peter Nilsson, Kitron's CEO, comments:
“On top of a strong underlying trend for Kitron in 2020, the Covid-19 pandemic created a temporary demand surge within the Medical devices market sector, leading to unusually strong growth and high margins. In 2021, we see a more normalized market and expect to follow our long-term growth and margin trajectory. Looking ahead, we see exciting business opportunities related to megatrends within electrification and connectivity.”

Solid revenue and order backlog
Kitron's revenue in the fourth quarter amounted to NOK 992 million, compared to 889 million in the same quarter last year. Revenue growth compared to the same quarter last year was particularly strong in the Industry market sector. As expected, the Medical sector normalized after extraordinarily high activity in the second and third quarter.

The order backlog ended at NOK 2 006 million, compared to 1 884 million last year. The order backlog increased the most within Energy/Telecom and Industry.

Strong profitability
Fourth quarter operating profit (EBIT) was NOK 75.7 million, compared to 54.2 million last year. EBITDA was NOK 102.2 million, compared to 82.2 million last year. Profit after tax amounted to NOK 47.1 million, compared to 34.0 million in the same quarter the previous year. This corresponds to earnings per share of NOK 0.26, up from 0.19 last year.

Outstanding full-year results
Full-year revenue of NOK 3 964 million gave an overall revenue growth of 20 per cent for the year. Operating profit (EBIT) for the year ended at NOK 312.6 million, compared to NOK 201.5 million, resulting in an EBIT margin of 7.9 per cent, compared to 6.1 per cent in 2019. Profit after tax was NOK 213.1 million, up from NOK 132.5 million, corresponding to NOK 1.19 earnings per share, compared to NOK 0.74 in 2019.

The Board of Directors proposes a dividend of NOK 0.70 per share for 2020. The Board proposes a changed policy of dividend payments in two equal tranches, one in May and one in October. Last year Kitron paid a dividend of NOK 0.50 per share.

Improved operating cash flow
Operating cash flow was NOK 132.2 million, compared to 97.2 million in the fourth quarter of 2019, recovering significantly from being temporarily challenged by the unusually strong growth in the second and third quarter. Net working capital was NOK 1 064 million, an increase of 13 per cent compared to the same quarter last year. As a percentage of revenue, net working capital was unchanged. Capital efficiency ratios are expected to improve further.

Outlook
For 2021, Kitron expects revenue between NOK 3 900 and 4 200 million. EBIT margin is expected to be between 6.8 and 7.4 per cent. The outlook for 2021 implies that Kitron is back on its long term trajectory for revenue and profitability after exceptional growth in 2020, largely driven by Corona-related demand within the Medical devices sector. Growth is driven by Defence/Aerospace, Electrification and Connectivity within Energy/Telecom and Industry Sectors. Medical devices is expected to be normalised and in line with previous years.

Enclosed in PDF are the quarterly report and the presentation. The interim report is presented today at 8:30 a.m. CET. The presentation will be given in English by CEO Peter Nilsson and CFO Cathrin Nylander, and will be webcast at the following link: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20210211_6

For further information, please contact:
Peter Nilsson, President and CEO, tel. +47 94 84 08 50
Cathrin Nylander, CFO, tel: +47 900 43 284
E-mail: investorrelations@kitron.com

Kitron is a leading Scandinavian electronics manufacturing services company for the Defence/Aerospace, Energy/Telecoms, Industry, Medical devices and Offshore/Marine sectors. The company is located in Norway, Sweden, Lithuania, Germany, Poland, China and the United States. Kitron had revenues of about NOK 4.0 billion in 2020 and has about 1 800 employees. www.kitron.com

This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.


Attachments


About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient self-testing using nasal swabs in Germany26.2.2021 18:30:00 CETPress release

Special approval from German Federal Institute for Drugs and Medical Devices (BfArM) enables home use of a SARS-CoV-2 Rapid Antigen Test using a simple nasal swabThe test will be widely available in pharmacies across Germany Basel, 26 February 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced it has been granted special approval by the German Federal Institute for Drugs and Medical Devices (BfArM) to offer the SARS-CoV-2 Rapid Antigen Test using a simple nasal swab for patient self-testing in Germany. The test is a reliable rapid test for the qualitative detection of a specific SARS-CoV-2 antigen in nasal swab samples.This rapid antigen test collects the sample from the front area of the nose instead of the nasopharynx, resulting in a simplified and more comfortable sampling procedure. By following simple instructions, patients can perform the test at home with results ready after only 15 minutes. The test will be made available in pharmacies and requires no prescription. The G

Cargotec Corporation: Share Repurchase 26.2.202126.2.2021 17:40:00 CETPress release

CARGOTEC CORPORATIONANNOUNCEMENT26.2.2021CARGOTEC CORPORATION: SHARE REPURCHASE 26.2.2021In the Helsinki Stock ExchangeTrade date26.2.2021Bourse tradeBuyShareCGCBVAmount40,362SharesAverage price/ share43.7441EURTotal cost1,765,599.36EURCargotec Corporation now holds a total of 300 531 sharesincluding the shares repurchased on 26.2.2021On behalf of Cargotec CorporationNordea Bank OyjJanne SarvikiviSami HuttunenFor further information, please contact:Mikko Puolakka, Executive Vice President and CFOtel. +358 20 777 4105Hanna-Maria Heikkinen, Vice President, Investor Relationstel. +358 20 777 4084www.cargotec.fi Attachment CGCBV_26.2_trades

Leasinvest Real Estate SCA sells the semi-industrial part of the Brixton Business Park in Zaventem26.2.2021 17:40:00 CETPress release

Today the deed has been executed regarding the sale of the semi-industrial part of the Brixton Business Park in Zaventem, as already announced in the latest press release regarding the 2020 annual results. The buyer is an affiliate of Exeter Property Group. Knight Frank acted as the broker in this transaction. The Brixton Business Park comprises 5 semi-industrial buildings with a total area of 18,788 sqm. This divestment is fully in line with the strategy of Leasinvest, which is aimed at selling non-strategic properties and focusing on new sustainable projects. The current favorable market situation enabled a successful sale of this type of property. This divestment also has favorable financial effects: not only does the debt ratio now reduce to the targeted level of less than 55%, the realized capital gain on this transaction has also allowed Leasinvest to expedite the reimbursement of part of our derivatives portfolio, thus further reducing the average financing cost following the ea

Incap Corporation: THE BOARD OF DIRECTORS OF INCAP HAS RESOLVED ON PAYING A PART OF THE PURCHASE PRICE PAYABLE TO THE SELLERS OF AWS ELECTRONICS GROUP IN NEW SHARES OF INCAP CORPORATION26.2.2021 16:30:00 CETPress release

INCAP CORPORATION STOCK EXCHANGE RELEASE 26 February 2021 at 5.30 p.m. (EET) THE PURCHASE OF AWS ELECTRONICS GROUP Incap Corporation (the “Company” or “Incap”) announced on 23 January 2020 that it has signed an agreement to acquire the entire share capital of AWS Electronics Group (“AWS”). The group has been included in Incap Group’s reporting as of 23 January 2020. The debt-free purchase price was 13.5 million pounds (then approximately EUR 15.9 million), and the additional purchase price amounted to EUR 0.6 million. The acquisition was financed with a loan of EUR 13 million and paid in cash, with the exception of an instalment of 0.6 million pounds to be paid in Incap shares. A PART OF THE PURCHASE PRICE The Board of Directors of the Company has on 26 February 2021 resolved, that the sellers of AWS will be paid an equivalent of 600,000 pounds in new shares of the Company in a directed share issue with payment (the “Share Issue”). The Share Issue will be consummated on 26 February 202

CONDITIONS FOR RIKSBANK REVERSED AUCTIONS SEK COVERED BONDS26.2.2021 16:20:00 CETPress release

Bid procedure, 2021-03-04BondsSWEDBANK HYPOTEK AB: 196. SE0015244991. 2026-03-18 STADSHYPOTEK AB: 1591, SE0013882644, 2026-06-01 SWEDISH COVERED BOND: 147, SE0009383664, 2026-06-17 SKANDINAVISKA ENSKILDA: 576, SE0010049841, 2023-12-20 LANSFORSAKRINGAR HYPOTEK: 519, SE0012324341, 2026-09-16 DANSKE HYPOTEK AB: 2512, SE0013877214, 2025-12-17 NORDEA HYPOTEK AB: 5534, SE0012230415, 2024-09-18 Bid date2021-03-04Bid times09.00-10.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)196: 800 mln SEK +/-400 mln SEK 1591: 2000 mln SEK +/-1000 mln SEK 147: 700 mln SEK +/-350 mln SEK 576: 700 mln SEK +/-350 mln SEK 519: 600 mln SEK +/-300 mln SEK 2512: 200 mln SEK +/-100 mln SEK 5534: 1000 mln SEK +/-500 mln SEK Highest permitted bid volume (corresponding nominal amount)196: 800 mln SEK per bid 1591: 2000 mln SEK per bid 147: 700 mln SEK per bid 576: 700 mln SEK per bid 519: 600 mln SEK per bid 2512: 200 mln SEK per bid 5534: 1000 mln SEK per bid Lowest permitted bid volume

CONDITIONS FOR RIKSBANK REVERSED AUCTIONS SEK GOVERNMENT BONDS26.2.2021 16:20:00 CETPress release

Bid procedure, 2021-03-05BondsSWEDEN I/L BOND: 3104. SE0000556599. 2028-12-01 SWEDEN I/L BOND: 3111, SE0007045745, 2032-06-01 Bid date2021-03-05Bid times09.00-10.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)3104: 500 mln SEK +/-250 mln SEK 3111: 500 mln SEK +/-250 mln SEK Highest permitted bid volume (corresponding nominal amount)3104: 500 mln SEK per bid 3111: 500 mln SEK per bid Lowest permitted bid volume (corresponding nominal amount)SEK 50 million per bidExpected allocation timeNot later than 10.15 (CET/CEST) on the Bid dateDelivery and payment date2021-03-09Delivery of bondsTo the Riksbank's account in Euroclear Sweden AB's securities settlement system 1 4948 6383 Stockholm, 2021-02-26 This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be

CONDITIONS FOR PURCHASES OF CORPORATE BONDS26.2.2021 16:20:00 CETPress release

Bid procedure, 2021-03-03BondsBonds issued in SEK by Swedish non-financial undertakings. The following bonds are eligible for delivery: INTEA FASTIGHETER AB: SE0010133470, 2022-07-05 INTEA FASTIGHETER AB: SE0013359817, 2025-09-01 LEJONFASTIGHETER AB: SE0009357635, 2022-09-05 LEJONFASTIGHETER AB: SE0012675924, 2022-11-29 RIKSHEM AB: SE0011452507, 2023-07-18 RIKSHEM AB: SE0011869643, 2022-05-20 KRAFTRINGEN ENERGI: SE0013882727, 2023-05-30 KRAFTRINGEN ENERGI: SE0013882735, 2024-05-30 EPIROC AB: XS1918042364, 2023-12-06 Delivery of a Bond may not occur if the Counterparty has purchased the Bond from the issuer more recently than one month prior to the date of announcement of the Special terms, that is, the purchase may not have taken place after: 2021-02-03Bid date2021-03-03Bid times10.00-11.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)SE0010133470: 30 mln SEK +/-30 mln SEK SE0013359817: 30 mln SEK +/-30 mln SEK SE0009357635: 30 mln SEK +/-30 mln SEK SE001267